AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. SRPT
  4. [8-K] Sarepta Therapeutics,, Inc. Reports Material Event

[8-K] Sarepta Therapeutics,, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock SRPT logo
Sarepta Therapeutics Inc

NASDAQ:SRPT

SRPT Rankings

#2114 Ranked by Market Cap
N/A Ranked by Dividends

SRPT Latest News

Aug 6, 2025
Sarepta Therapeutics Announces Second Quarter 2025 Financial Results and Recent Corporate Developments
Jul 31, 2025
Sarepta Therapeutics to Announce Second Quarter 2025 Financial Results
Jul 28, 2025
FDA Informs Sarepta That It Recommends That Sarepta Remove Its Pause and Resume Shipments of ELEVIDYS for Ambulatory Individuals With Duchenne Muscular Dystrophy
Jul 28, 2025
Arrowhead Pharmaceuticals Earns $100 Million Milestone from Sarepta Therapeutics
Jul 25, 2025
Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS

SRPT Latest SEC Filings

Aug 6, 2025
[Form 4] Sarepta Therapeutics,, Inc. Insider Trading Activity
Aug 6, 2025
[Form 4] Sarepta Therapeutics,, Inc. Insider Trading Activity
Aug 6, 2025
[Form 4] Sarepta Therapeutics,, Inc. Insider Trading Activity
Aug 6, 2025
[S-8] Sarepta Therapeutics,, Inc. Employee Benefit Plan Registration
Aug 4, 2025
[Form 4] Sarepta Therapeutics,, Inc. Insider Trading Activity

SRPT Stock Data

1.78B
93.36M
4.42%
96.65%
15.12%
Biotechnology
Pharmaceutical Preparations
United States
CAMBRIDGE